litlas
ログインアカウント作成

Shibo Jiang

1993–2025 年に発表

240
論文数
37,296
被引用数
105
h 指数
233
i10 指数

被引用数

Shibo Jiang の年別被引用数1974 年: 被引用 1 件1978 年: 被引用 3 件1979 年: 被引用 1 件1982 年: 被引用 1 件1987 年: 被引用 1 件1988 年: 被引用 1 件1991 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 9 件1996 年: 被引用 2 件1997 年: 被引用 8 件1998 年: 被引用 8 件1999 年: 被引用 12 件2000 年: 被引用 19 件2001 年: 被引用 13 件2002 年: 被引用 23 件2003 年: 被引用 15 件2004 年: 被引用 51 件2005 年: 被引用 88 件2006 年: 被引用 103 件2007 年: 被引用 97 件2008 年: 被引用 111 件2009 年: 被引用 125 件2010 年: 被引用 117 件2011 年: 被引用 60 件2012 年: 被引用 78 件2013 年: 被引用 119 件2014 年: 被引用 166 件2015 年: 被引用 180 件2016 年: 被引用 245 件2017 年: 被引用 140 件2018 年: 被引用 149 件2019 年: 被引用 595 件2020 年: 被引用 4,967 件2021 年: 被引用 3,834 件2022 年: 被引用 1,851 件2023 年: 被引用 968 件2024 年: 被引用 1,262 件2025 年: 被引用 471 件2026 年: 被引用 12 件1975〜1977 年は被引用が無いため表示していません1980〜1981 年は被引用が無いため表示していません1983〜1986 年は被引用が無いため表示していません1989〜1990 年は被引用が無いため表示していません1992〜1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,392 件、この内訳の 21.2%中国: 引用元論文 2,748 件、この内訳の 17.2%インド: 引用元論文 921 件、この内訳の 5.8%イギリス: 引用元論文 729 件、この内訳の 4.6%イタリア: 引用元論文 561 件、この内訳の 3.5%ドイツ: 引用元論文 509 件、この内訳の 3.2%カナダ: 引用元論文 428 件、この内訳の 2.7%イラン: 引用元論文 396 件、この内訳の 2.5%フランス: 引用元論文 361 件、この内訳の 2.2%オーストラリア: 引用元論文 337 件、この内訳の 2.1%韓国: 引用元論文 295 件、この内訳の 1.8%サウジアラビア: 引用元論文 289 件、この内訳の 1.8%
0%21.2%その他 31.4%

機関

分野

  • Medicine70.3%
  • Biochemistry, Genetics and Molecular Biology10.8%
  • Immunology and Microbiology7.2%
  • Computer Science2.9%
  • Agricultural and Biological Sciences2.6%
  • Engineering1.1%
  • その他5.1%

トピック

  • SARS-CoV-2 and COVID-19 Research19.2%
  • COVID-19 Clinical Research Studies11.7%
  • Animal Virus Infections Studies3.8%
  • SARS-CoV-2 detection and testing3.4%
  • Long-Term Effects of COVID-193.4%
  • Viral gastroenteritis research and epidemiology3.1%
  • その他55.4%

共著者

全論文

検索で開く
  1. Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses

    著者: Yanjia Chen, Xiaoyu Zhao, Hao Zhou, Huanzhang Zhu, Shibo Jiang, Pengfei Wang - Nature reviews. Immunology 2022 被引用: 404

  2. Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

    著者: Shuai Xia, Meiqin Liu, Chao Wang, Wei Xu, Qiaoshuai Lan, Siliang Feng, Feifei Qi, Linlin Bao, Lanying Du, Shuwen Liu, Chuan Qin, Fei Sun, Zhengli Shi, Yun Zhu, Shibo Jiang, Lu Lu - Cell Research 2020 被引用: 1,438

  3. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

    著者: Wanbo Tai, Lei He, Xiujuan Zhang, Jing Pu, Denis Voronin, Shibo Jiang, Yusen Zhou, Lanying Du - Cellular and Molecular Immunology 2020 被引用: 1,814

  4. AXL is a candidate receptor for SARS-CoV-2 that promotes infection of pulmonary and bronchial epithelial cells

    著者: Shuai Wang, Zongyang Qiu, Yingnan Hou, Xiya Deng, Wei Xu, Tingting Zheng, Peihan Wu, Shaofang Xie, Weixiang Bian, Chong Zhang, Zewei Sun, Kunpeng Liu, Chao Shan, Aifu Lin, Shibo Jiang, Youhua Xie, Qiang Zhou, Lu Lu, Jing Huang, Xu Li - Cell Research 2021 被引用: 511

  5. The spike protein of SARS-CoV — a target for vaccine and therapeutic development

    著者: Lanying Du, Yuxian He, Yusen Zhou, Shuwen Liu, Bo-Jian Zheng, Shibo Jiang - Nature Reviews Microbiology 2009 被引用: 1,772

  6. Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody

    著者: Cheng Li, Wuqiang Zhan, Zhenlin Yang, Chao Tu, Gaowei Hu, Xiang Zhang, Wenping Song, Shujuan Du, Yuanfei Zhu, Keke Huang, Yu Kong, Meng Zhang, Qiyu Mao, Xiaodan Gu, Yi Zhang, Youhua Xie, Qiang Deng, Yuanlin Song, Zhenguo Chen, Lu Lu, Shibo Jiang, Yanling Wu, Lei Sun, Tianlei Ying - Cell 2022 被引用: 189

  7. Pulmonary surfactant–biomimetic nanoparticles potentiate heterosubtypic influenza immunity

    著者: Ji Wang, Peiyu Li, Yang Yu, YuHong Fu, Hongye Jiang, Min Lu, Zhiping Sun, Shibo Jiang, Lu Lu, Mei X. Wu - Science 2020 被引用: 307

  8. Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy

    著者: Hongjing Gu, Qi Chen, Guan Yang, Lei He, Hang Fan, Yong‐Qiang Deng, Yanxiao Wang, Yue Teng, Zhongpeng Zhao, Yujun Cui, Yuchang Li, Xiao-Feng Li, Jiangfan Li, Na-Na Zhang, Xiaolan Yang, Shaolong Chen, Yan Guo, Guangyu Zhao, Xiliang Wang, Deyan Luo, Hui Wang, Xiao Yang, Yan Li, Gencheng Han, Yuxian He, Xiaojun Zhou, Shusheng Geng, Xiaoli Sheng, Shibo Jiang, Shihui Sun, Cheng‐Feng Qin, Yusen Zhou - Science 2020 被引用: 848

  9. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy

    著者: Qianqian Zhang, Rong Xiang, Shanshan Huo, Yunjiao Zhou, Shibo Jiang, Qiao Wang, Fei Yu - Signal Transduction and Targeted Therapy 2021 被引用: 353

  10. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein

    著者: Shuai Xia, Yun Zhu, Meiqin Liu, Qiaoshuai Lan, Wei Xu, Yanling Wu, Tianlei Ying, Shuwen Liu, Zhengli Shi, Shibo Jiang, Lu Lu - Cellular and Molecular Immunology 2020 被引用: 758

  11. Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines

    著者: Lang Rao, Shuai Xia, Wei Xu, Rui Tian, Guocan Yu, Chenjian Gu, Pan Pan, Qian-Fang Meng, Xia Cai, Di Qu, Lu Lu, Youhua Xie, Shibo Jiang, Xiaoyuan Chen - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 被引用: 258

  12. Antivirals with common targets against highly pathogenic viruses

    著者: Lu Lu, Shan Su, Haitao Yang, Shibo Jiang - Cell 2021 被引用: 165

  13. Recent advances in the detection of respiratory virus infection in humans

    著者: Naru Zhang, Lili Wang, Xiaoqian Deng, Ruiying Liang, Meng Su, Chen He, Lanfang Hu, Yudan Su, Jing Ren, Fei Yu, Lanying Du, Shibo Jiang - Journal of Medical Virology 2020 被引用: 572

  14. In silico design of a DNA-based HIV-1 multi-epitope vaccine for Chinese populations

    著者: Yi Yang, Weilai Sun, Jingjing Guo, Guangyu Zhao, Shihui Sun, Hong Yu, Yan Guo, Jungfeng Li, Xia Jin, Lanying Du, Shibo Jiang, Zhihua Kou, Yusen Zhou - Human Vaccines & Immunotherapeutics 2015 被引用: 153

  15. Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variants

    著者: Cun Li, Jingjing Huang, Yifei Yu, Zhixin Wan, Man Chun Chiu, Xiaojuan Liu, Shuxin Zhang, Jian‐Piao Cai, Hin Chu, Gang Li, Jasper Fuk‐Woo Chan, Kelvin Kai‐Wang To, Zifeng Yang, Shibo Jiang, Kwok‐Yung Yuen, Hans Clevers, Jie Zhou - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 被引用: 69

  16. A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

    著者: Shuai Xia, Lei Yan, Wei Xu, Anurodh Shankar Agrawal, Abdullah Algaissi, Chien‐Te K. Tseng, Qian Wang, Lanying Du, Wenjie Tan, Ian A. Wilson, Shibo Jiang, Bei Yang, Lu Lu - Science Advances 2019 被引用: 529

  17. Receptor usage and cell entry of bat coronavirus HKU4 provide insight into bat-to-human transmission of MERS coronavirus

    著者: Yang Yang, Lanying Du, Chang Liu, Lili Wang, Cuiqing Ma, Jian Tang, Ralph S. Baric, Shibo Jiang, Fang Li - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 被引用: 299

  18. Receptor Usage and Cell Entry of Porcine Epidemic Diarrhea Coronavirus

    著者: Chang Liu, Jian Tang, Yuanmei Ma, Xueya Liang, Yang Yang, Guiqing Peng, Qianqian Qi, Shibo Jiang, Jiànróng Lǐ, Lanying Du, Fang Li - Journal of Virology 2015 被引用: 271

  19. SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: unexpected consequences

    著者: Xinling Wang, Lu Lu, Shibo Jiang - Trends in Immunology 2024 被引用: 52

  20. Potential cross-species transmission of highly pathogenic avian influenza H5 subtype (HPAI H5) viruses to humans calls for the development of H5-specific and universal influenza vaccines

    著者: Pan Huang, Lujia Sun, Jinhao Li, Qingyi Wu, Nima Rezaei, Shibo Jiang, Chungen Pan - Cell Discovery 2023 被引用: 70

  21. A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 Omicron variant

    著者: Man Chun Chiu, Cun Li, Xiaojuan Liu, Yifei Yu, Jingjing Huang, Zhixin Wan, Ding Xiao, Hin Chu, Jian‐Piao Cai, Biao Zhou, Ko‐Yung Sit, Wing‐Kuk Au, Kenneth Kak‐Yuen Wong, Gang Li, Jasper Fuk‐Woo Chan, Kelvin Kai‐Wang To, Zhiwei Chen, Shibo Jiang, Hans Clevers, Kwok‐Yung Yuen, Jie Zhou - Cell Discovery 2022 被引用: 80

  22. Quercetin as an Antiviral Agent Inhibits Influenza A Virus (IAV) Entry

    著者: Wenjiao Wu, Richan Li, Xianglian Li, Jian He, Shibo Jiang, Shuwen Liu, Jie Yang - Viruses 2015 被引用: 429

  23. Identification of Human Single-Domain Antibodies against SARS-CoV-2

    著者: Yanling Wu, Cheng Li, Shuai Xia, Xiaolong Tian, Yu Kong, Zhi Wang, Chenjian Gu, Rong Zhang, Chao Tu, Youhua Xie, Zhenlin Yang, Lu Lu, Shibo Jiang, Tianlei Ying - Cell Host & Microbe 2020 被引用: 281

  24. A variant-proof SARS-CoV-2 vaccine targeting HR1 domain in S2 subunit of spike protein

    著者: Wei Pang, Ying Lu, Yan‐Bo Zhao, Fan Shen, Changfa Fan, Qian Wang, Wen-Qiang He, Xiao-Yan He, Zekai Li, Taotao Chen, Cuixian Yang, You-Zhi Li, Si-Xuan Xiao, Zu-Jiang Zhao, Xusheng Huang, Rong‐Hua Luo, Liu‐Meng Yang, Mi Zhang, Xingqi Dong, Minghua Li, Xiaoli Feng, Qing-Cui Zhou, Wang Qu, Shibo Jiang, Songying Ouyang, Yong‐Tang Zheng - Cell Research 2022 被引用: 79